Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed GBM.

NCT00916409 is registered in ClinicalTrials.gov with NovoCure Ltd. as lead sponsor.

NCT NCT00916409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00916409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed GBM.
Lead sponsor
NovoCure Ltd.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2009
Completion date
March 31, 2017
Enrollment
700 (estimated)
Sites
89

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme